ALIM Insider Trading Activity and SEC Form 4 Filings
ALIM insider trading summary
No open-market insider purchases or sales of Alimera Sciences Inc (ALIM) have been reported on SEC Form 4 in the past 12 months.
Latest ALIM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 14, 2023 | David Edward Johnson | 10% Owner | Sell | $2.0M (579,000 @ $3.39) |
| Sep 14, 2023 | Caligan Partners LP | 10% Owner | Buy | $2.0M (579,000 @ $3.39) |
| Sep 14, 2023 | David Edward Johnson | 10% Owner | Buy | $2.0M (579,000 @ $3.39) |
| Sep 14, 2023 | Caligan Partners LP | 10% Owner | Sell | $2.0M (579,000 @ $3.39) |
| May 17, 2023 | Adam Morgan | Director | Buy | $2.4M (1,401,901 @ $1.70) |
| Mar 24, 2023 | Palo Alto Investors LP | Insider | Sell | $314K (200,919 @ $1.56) |
| Feb 8, 2022 | Stanley Morgan | 10% Owner | Sell | $1.1M (250,000 @ $4.55) |
| Dec 15, 2021 | Richard S Eiswirth Jr | President and CEO | Buy | $2K (484 @ $4.50) |
| Dec 3, 2021 | Richard S Eiswirth Jr | President and CEO | Buy | $24K (5,000 @ $4.80) |
| Dec 2, 2021 | Richard S Eiswirth Jr | President and CEO | Buy | $24K (5,000 @ $4.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.